The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
Clinical trial NCT02098395 · COMPLETED
Trial details
- NCT number
- NCT02098395
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-01
- Primary completion
- 2015-04-01
- Enrollment
- 835
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.